Boston Scientific lifts annual profit forecast on strong demand for heart devices

Boston Scientific raised its annual profit forecast on Wednesday, after beating third-quarter profit estimates on strong ...
TipRanks on MSN

Boston Scientific’s FARAFLEX Study: A Potential Game-Changer in Atrial Fibrillation Treatment

Boston Scientific (($BSX)) announced an update on their ongoing clinical study. Study Overview: The study titled ‘Feasibility Study of the ...
Nasdaq

Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System

MARLBOROUGH, Mass., July 7, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the instructions for use (IFU) ...
Insider Monkey

Boston Scientific Corp (BSX) Secures FDA Labeling Expansion for FARAPULSE Pulsed Field Ablation (PFA) System

Boston Scientific Corporation (NYSE:BSX) is one of Goldman Sachs’ top healthcare stock picks. On July 7, Boston Scientific (NYSE:BSX) saw its shares rise as TD Cowen reaffirmed its Buy rating and $115 ...
MassDevice

Boston Scientific sales grow more than 20% in Street-beating Q3

Boston Scientific (NYSE: BSX) shares ticked up before hours today on third-quarter results that came in ahead of the ...